(19)
(11) EP 4 496 809 A1

(12)

(43) Date of publication:
29.01.2025 Bulletin 2025/05

(21) Application number: 23712268.4

(22) Date of filing: 21.03.2023
(51) International Patent Classification (IPC): 
C07K 16/22(2006.01)
A61K 39/395(2006.01)
 A61P 19/02(2006.01)
(52) Cooperative Patent Classification (CPC):
C07K 16/22; A61P 19/02; A61K 2039/505; A61K 2039/545; A61K 2039/54
(86) International application number:
PCT/EP2023/057131
(87) International publication number:
WO 2023/180276 (28.09.2023 Gazette 2023/39)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 22.03.2022 EP 22305337

(71) Applicant: Netris Pharma
69008 Lyon (FR)

(72) Inventors:
  • SVENSSON, Camilla
    11418 STOCKHOLM (SE)
  • RUDJITO, Resti
    75644 UPPSALA (SE)
  • NEVES, David
    69390 VERNAISON (FR)

(74) Representative: Lavoix 
62, rue de Bonnel
69448 Lyon Cedex 03
69448 Lyon Cedex 03 (FR)

   


(54) ANTI-NETRIN-1 ANTIBODY AGAINST ARTHRITIS-ASSOCIATED PAIN